Provided by Tiger Trade Technology Pte. Ltd.

Cartesian Therapeutics

10.21
+0.17001.69%
Volume:70.26K
Turnover:700.02K
Market Cap:308.91M
PE:-1.76
High:10.29
Open:10.05
Low:9.50
Close:10.04
52wk High:11.39
52wk Low:5.60
Shares:30.26M
Float Shares:12.40M
Volume Ratio:0.55
T/O Rate:0.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.7983
EPS(LYR):-5.0200
ROE:-7029.26%
ROA:-17.43%
PB:-2.47
PE(LYR):-2.03

Loading ...

May 08, 2024

Major Issues Report

Form 8-K - Current report
Apr 22, 2024

Major Issues Report

Form 8-K - Current report
Apr 12, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Apr 10, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Apr 10, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Apr 09, 2024

Major Issues Report

Form 8-K - Current report
Apr 02, 2024

Major Issues Report

Form 8-K - Current report
Mar 28, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Mar 28, 2024

Major Issues Report

Form 8-K - Current report
Mar 14, 2024

Major Issues Report

Form 8-K - Current report
Mar 07, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 07, 2024

Major Issues Report

Form 8-K - Current report
Mar 05, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 09, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 24, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Jan 19, 2024

Major Issues Report

Form 8-K - Current report
Jan 13, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Dec 01, 2023

Correspondence

Form CORRESP - Correspondence